708-1253

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-05-07

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild CONJUNCTIVITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed

Mild CONJUNCTIVITIS — outcome: RECOVERED/RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed

Mild COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed

Mild COUGH — outcome: RECOVERED/RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed

Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-07 (study day 32.0); relationship: POSSIBLE

mild assessed

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-06-07 (study day 32.0); relationship: POSSIBLE

mild assessed

Mild HEART RATE INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-07 (study day 1.0); relationship: POSSIBLE

mild assessed

Mild HEART RATE INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-05-07 (study day 1.0); relationship: POSSIBLE

Data queries

No data queries.